Clinical trials: Continuous Glucose Monitoring
Diabetes Mellitus
Effectiveness and Safety of the RIGHTEST™ CGM System for Blood Glucose Management in Persons With Diabetes Mellitus
The trial is expected to enroll 50 confirmed cases of type 1 or type 2 diabetes. All eligible subjects must wear a continuous glucose monitoring system on both the left and right upper arms for a maximum of 15 days (360 hours)…
- Trial name
- NCT07888582
- Testing
- RIGHTEST Continuous Glucose Monitoring System
- Where
- Germany
- Volunteers
- 50 people
- Sponsor
- Bionime Corporation
Diabetes Mellitus, Type 1 Diabetes
Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus
The purpose of this study is to evaluate the effectiveness and safety of the RIGHTEST Continuous Monitoring (CGM) System in adult population with diabetes mellitus.
- Conditions
- Diabetes Mellitus, Type 1 Diabetes, Type 2 Diabetes
- Trial name
- NCT04838392
- Testing
- RIGHTEST Continuous Glucose Monitoring System
- Where
- 13 sites in United States
- Volunteers
- 150 people
- Sponsor
- Bionime Corporation
Diabetes Mellitus
Comparison of the Efficacy and Safety of GLARGEN® Versus NPH Insulin in Diabetic Tunisian Patients.
This study will have a single arm: the patient on NPH will continue his treatment for 4 weeks, at the end of the NPH treatment, the patient will receive his CGM device for three days for glycemic holter, a switch to insulin…
- Trial name
- GRANT (NCT06999551)
- Testing
- switch NPH to glargin
- Where
- Tunisia
- Volunteers
- 60 people
- Sponsor
- Les Laboratoires des Médicaments Stériles
Diabetes Type 1
InPen User Experience
The purpose of this study is to evaluate the user experience of InPen™ with InPen™ Diabetes Management App and Guardian 4 system in adult patients with type 1 diabetes for the design of a future pivotal study.
- Trial name
- NCT05029271
- Testing
- InPen with Guardian 4 System
- Where
- 3 sites in Sweden
- Volunteers
- 34 people
- Sponsor
- Medtronic MiniMed, Inc.
Adult Intensive Care Patients
GlySure Acute Care Settings Study
The company who have developed the GlySure product have previously carried out a study to be able to show that the GlySure system is accurate in measuring blood sugar (glucose) levels.
- Trial name
- NCT02421107
- Testing
- Glysure CGM, iStat intermittent testing
- Volunteers
- 40 people
- Sponsor
- GlySure
Diabetes Mellitus
Observational, Data Collection Study for Subjects With Diabetes Using Insulin Injections
This is an observational, multicenter prospective study including up to 260 subjects with type 1 or type 2 diabetes who use insulin injections (either basal insulin only or multiple daily injections (MDI)) and CGM or SMBG to…
- Trial name
- NCT04013919
- Testing
- Multiple Daily Injections of Insulin, Single insulin injections
- Where
- Israel
- Volunteers
- 260 people
- Sponsor
- DreaMed Diabetes
Diabetes, Pre-diabetes
Glucose Risk Assessment in Employer Populations
This is an observational study to understand the glucose characteristics of the general population (normal glucose, pre-diabetes, and diabetes).
- Conditions
- Diabetes, Pre-diabetes, Glucose Intolerance
- Trial name
- NCT04529824
- Testing
- Dexcom G6 Continuous Glucose Monitor (CGM) System
- Where
- United States
- Volunteers
- 207 people, healthy volunteers welcome
- Sponsor
- DexCom, Inc.
Type 2 Diabetes Treated With Insulin
Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland
The goal of this clinical study is to determine the impact of starting the use of the FreeStyle Libre 2 glucose monitoring system, over a three month period, on HbA1c in adults with type 2 diabetes treated with a basal insulin…
- Trial name
- NCT06268821
- Testing
- FreeStyle Libre 2 Flash Glucose Monitoring System
- Where
- 2 sites in Finland
- Volunteers
- 11 people
- Sponsor
- Abbott Diabetes Care
Glucose Monitoring, Continuous, Whole Body Protein Metabolism
Effects of Amylopectin Chromium Blend on Whole-Body Protein Kinetics and Glucose in Peri/Post-Menopausal Women
The goal of this study is to better understand how an amylopectin chromium blend may influence whole body protein balance in women during midlife, when hormonal changes can adversely affect protein metabolism and muscle…
- Conditions
- Glucose Monitoring, Continuous, Whole Body Protein Metabolism, Peri-menopausal Women, Post-menopause
- Trial name
- NCT07402382
- Testing
- Amylopectin-chromium blend, Concentrated Amylopectin-chromium blend
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Nutrition 21, Inc.
Diabetes
Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With Diabetes
The aim of this clinical trial is to evaluate whether the COVER PATCH adhesive patch can improve the adhesion of continuous glucose monitors (CGMs).
- Trial name
- ICP-COVERPATCH (NCT07018180)
- Testing
- Use of COVER patchs for continuous glucose monitoring sensor
- Where
- 7 sites in France, Guadeloupe
- Volunteers
- 194 people
- Sponsor
- CAPTEUR PROTECT
Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 2
RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study
This study will evaluate the accuracy and safety of the RIGHTEST iFree 2 Continuous Glucose Monitoring (CGM) System in pregnant women with type 1 diabetes, type 2 diabetes, or gestational diabetes.
- Conditions
- Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 2, Diabetes, Gestational
- Trial name
- NCT07889388
- Testing
- RIGHTEST iFree 2 Continuous Glucose Monitoring System
- Where
- Germany
- Volunteers
- 104 people
- Sponsor
- Bionime Corporation
Diabetes (DM)
Clinical and Home Use Feasibility Study of a Percutaneous Optical Glucose Fiber Sensor
This is a single-centre, open label (unblinded) prospective study investigating the performance and safety of FiberSense system in diabetic patients (Typ I and II).
- Trial name
- NCT04152408
- Testing
- FiberSense System
- Where
- Germany
- Volunteers
- 7 people
- Sponsor
- EyeSense GmbH
Type 2 Diabetes Treated With Insulin
Initiation of Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin, in Italy
The goal of this clinical study is to determine the impact of starting the use of the FreeStyle Libre 2 glucose monitoring system, over a three month period, on HbA1c in adults with type 2 diabetes treated with a basal insulin…
- Trial name
- NCT06268808
- Testing
- FreeStyle Libre 2 Flash Glucose Monitoring System
- Where
- 8 sites in Italy
- Volunteers
- 90 people
- Sponsor
- Abbott Diabetes Care
Type 1 Diabetes Mellitus
Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients
Primary Objective: To demonstrate the non-inferiority of insulin glargine 300 units per milliliter (U/ml) in comparison to insulin degludec 100 U/ml on glycemic control and variability in participants with diabetes mellitus.
- Trial name
- inRange (NCT04075513)
- Testing
- Insulin glargine, 300 U/ml, Insulin degludec, 100U/ml, Background therapy: Rapid acting insulin analogs
- Where
- 7 sites in United States, Brazil and 5 more
- Volunteers
- 343 people
- Sponsor
- Sanofi
Type 1 Diabetes
A Feasibility Study to Evaluate the Performance of the Harmony 1 Sensors in Adults and Pediatrics
The purpose of this study is to demonstrate the performance of the Harmony 1 Sensor in subjects age 14 - 75 years.
- Trial name
- NCT02646878
- Testing
- Harmony 1 Sensor
- Sponsor
- Medtronic MiniMed, Inc.
Diabetes
Performance of the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus
The purpose of this prospective observational study is to establish the performance and safety of the Dexcom G6 CGM System utilized for up to a 10-day wear period in pregnant women with diabetes mellitus.
- Trial name
- NCT03935191
- Testing
- Dexcom CGM System
- Volunteers
- 60 people
- Sponsor
- DexCom, Inc.
Diabetes Mellitus
Accuracy and Precision of the True Vie I3 Continuous Glucose Monitoring System: an Open Label, Multi-Center Trial
The purpose of the investigation is to evaluate the performance of the I3 CGM according to the FDA's special controls for iCGM.
- Trial name
- NCT05806554
- Testing
- Continuous glucose monitoring device
- Where
- 6 sites in United States, Germany
- Volunteers
- 159 people
- Sponsor
- Sinocare
Diabetes Mellitus
Use of Mellitor Sensor for Continuous Glucose Monitoring - An Ex-Vivo Study
Most patients with diabetes mellitus have to measure their blood glucose levels quite often, in order to maintain a proper glycemic control.
- Trial name
- NCT00746642
- Testing
- Mellitor device for glucose measurement
- Where
- Israel
- Volunteers
- 20 people
- Sponsor
- Mellitor
Iron Overload, Hemoglobinopathies
Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group
A prospective, observational, comparative study with no intervention.The objective of the study to compare the efficiency of detecting glycemic abnormalities using Continuous Glucose Monitoring (CGMs) versus Oral Glucose…
- Conditions
- Iron Overload, Hemoglobinopathies, Lymphoma, Acute Lymphoblastic Leukemia
- Trial name
- CGMs (NCT03141398)
- Testing
- Continuous Glucose Monitoring (CGM), Oral Glucose Tolerance Test (OGTT), T2* MRI of the Pancreas
- Sponsor
- Hamad Medical Corporation
Glucose Metabolism Disorders
Continuous Glucose Monitoring During Diets That Differ in Glycemic Load
This study test whether a Continuous Glucose Monitor can pickup differences in glucose (in the interstitial fluid) during a dietary intervention using meals with either a high with a low glycemic load.
- Trial name
- GLOW (NCT02926118)
- Testing
- Low glycemic load, High glycemic load
- Where
- Netherlands
- Volunteers
- 23 people, healthy volunteers welcome
- Sponsor
- Unilever R&D